Cyclerion Therapeutics, Inc. (CYCN) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 3.09M | 4.63M | 5.07M | 4.02M | 4.5M | 4.22M | 3.55M | 4.71M | 6.01M | 8.02M | 9.86M | 7.11M | 8.34M | 14.82M | 21.66M | 31.68M | 42.84M | 55.46M | 63.68M | 72.99M |
| Cash & Short-Term Investments | 2.82M | 3.24M | 4.57M | 3.01M | 3.64M | 3.23M | 2.87M | 4.59M | 5.7M | 7.57M | 9.11M | 5.64M | 7.17M | 13.38M | 20.41M | 30.32M | 41.13M | 53.96M | 62.5M | 70.39M |
| Cash Only | 2.82M | 3.24M | 4.57M | 3.01M | 3.64M | 3.23M | 2.87M | 4.59M | 5.7M | 7.57M | 9.11M | 5.64M | 7.17M | 13.38M | 20.41M | 30.32M | 41.13M | 53.96M | 62.5M | 70.39M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 1M | 100K | 525K | 581K | 556K | 44K | 0 | 0 | 0 | 0 | 0 | 96K | 96K | 227K | 227K | 227K | 100K | 158K | 0 |
| Days Sales Outstanding | - | 49.37 | 32.86 | 541.11 | 631.67 | 15.28 | 20.87 | - | - | - | - | - | - | - | - | 67.51 | 20.7 | 22.27 | 41.77 | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 928K | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.16 | - | - |
| Other Current Assets | 266K | 11K | 397K | 489K | 21K | 16K | 11K | 11K | 10K | 11K | 30K | 428K | 503K | 537K | 488K | 482K | 477K | 468K | 59K | 33K |
| Total Non-Current Assets | 5.42M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 2.98M | 3.12M | 3.26M | 3.4M | 3.53M | 3.69M | 3.87M | 4.06M | 2.74M |
| Property, Plant & Equipment | 66K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.13M | 1.17M | 1.22M | 1.26M | 1.31M | 1.37M | 1.47M | 1.56M | 153K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.23x | 0.50x | 0.35x | 0.41x | 0.12x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 5.35M | 0 | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 5.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 5.35M | 0 | 5.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.86M | 1.95M | 2.04M | 2.13M | 2.22M | 2.32M | 2.41M | 2.5M | 2.59M |
| Total Assets | 8.51M | 9.98M | 10.41M | 9.37M | 9.85M | 9.57M | 8.9M | 10.06M | 11.36M | 13.37M | 15.21M | 10.1M | 11.46M | 18.08M | 25.05M | 35.21M | 46.52M | 59.33M | 67.74M | 75.73M |
| Asset Turnover | - | 0.10x | 0.09x | 0.01x | 0.01x | 0.20x | 0.02x | - | - | - | - | - | - | - | - | 0.01x | 0.01x | 0.01x | 0.00x | 0.03x |
| Asset Growth % | -13.63% | 4.28% | 17.05% | -6.91% | -13.35% | -28.41% | -41.51% | -0.32% | -0.8% | -26.02% | -39.27% | -71.33% | -75.38% | -69.53% | -63.02% | -53.5% | -53.46% | -48.58% | -48.45% | -40.85% |
| Total Current Liabilities | 1.71M | 900K | 877K | 800K | 1.07M | 725K | 700K | 1.28M | 1.44M | 2.09M | 2.34M | 4.95M | 7.53M | 7.63M | 8.53M | 9.85M | 9.49M | 11.09M | 11.36M | 10.51M |
| Accounts Payable | 457K | 508K | 480K | 462K | 483K | 390K | 304K | 651K | 741K | 1.2M | 814K | 1.86M | 3.92M | 2.97M | 1.65M | 2.77M | 2.52M | 1.83M | 1.17M | 1.39M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | 776.99 | 542.44 | 273.57 | - | 23.54 | 20.08 | 13.2 | 16.75 | 9.37 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.51M | 3.51M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.26M | 51K | 397K | 338K | 45K | 63K | 396K | 616K | 678K | 102K | 1.5M | 2.56M | 140K | 68K | 159K | 195K | 386K | 7.28M | 833K | 222K |
| Current Ratio | 1.80x | 5.15x | 5.78x | 5.03x | 4.21x | 5.83x | 5.07x | 3.68x | 4.17x | 3.85x | 4.21x | 1.44x | 1.11x | 1.94x | 2.54x | 3.22x | 4.51x | 5.00x | 5.61x | 6.94x |
| Quick Ratio | 1.80x | 5.15x | 5.78x | 5.03x | 4.21x | 5.83x | 5.07x | 3.68x | 4.17x | 3.85x | 4.21x | 1.44x | 1.11x | 1.94x | 2.54x | 3.22x | 4.51x | 4.92x | 5.61x | 6.94x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 17.23 | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Total Liabilities | 1.71M | 900K | 877K | 800K | 1.07M | 725K | 700K | 1.28M | 1.44M | 2.09M | 2.34M | 4.95M | 7.53M | 7.63M | 8.53M | 9.85M | 9.49M | 11.09M | 11.36M | 10.51M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.51M | 3.51M |
| Net Debt | -2.82M | -3.24M | -4.57M | -3.01M | -3.64M | -3.23M | -2.87M | -4.59M | -5.7M | -7.57M | -9.11M | -5.64M | -7.17M | -13.38M | -20.41M | -30.32M | -41.13M | -53.96M | -58.99M | -66.88M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.06x | 0.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | -6.44x | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -14338.00x | -2257.00x | -2549.17x |
| Total Equity | 6.79M | 9.09M | 9.54M | 8.57M | 8.78M | 8.85M | 8.2M | 8.78M | 9.92M | 11.29M | 12.87M | 5.15M | 3.92M | 10.45M | 16.52M | 25.36M | 37.03M | 48.25M | 56.39M | 65.22M |
| Equity Growth % | -22.65% | 2.66% | 16.35% | -2.43% | -11.52% | -21.6% | -36.32% | 70.54% | 152.82% | 8% | -22.1% | -79.69% | -89.4% | -78.34% | -70.7% | -61.12% | -23.54% | -18.9% | -25.17% | -1.33% |
| Book Value per Share | 1.61 | 2.82 | 2.96 | 2.79 | 3.44 | 3.48 | 3.25 | 3.50 | 3.98 | 4.56 | 5.29 | 2.26 | 1.80 | 4.80 | 8.00 | 12.27 | 17.92 | 23.41 | 26.05 | 36.53 |
| Total Shareholders' Equity | 6.79M | 9.09M | 9.54M | 8.57M | 8.78M | 8.85M | 8.2M | 8.78M | 9.92M | 11.29M | 12.87M | 5.15M | 3.92M | 10.45M | 16.52M | 25.36M | 37.03M | 48.25M | 56.39M | 65.22M |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -274.2M | -271.02M | -270.22M | -269.25M | -268.92M | -267.49M | -268.02M | -267.3M | -265.96M | -264.42M | -262.72M | -270.29M | -266.11M | -259.15M | -251.94M | -241.44M | -228.05M | -215.08M | -204.3M | -193.01M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16K | -12K | -18K | -16K | -19K | -20K | -28K | -25K | -24K | -23K | -26K | -26K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |